/Companies

Cellbioengines

Founded 2022 · 5 employees on LinkedIn · 2 known investors

Find your way into Cellbioengines

Sign up to see every warm intro you have to Cellbioengines

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cellbioengines team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cell BioEngines is a clinical-stage biotech company developing allogeneic "off-the-shelf" cell therapies from "super donor" stem cells, using transgene-free scalable manufacturing and HLA-guided design. It pursues stem cell-derived therapeutics across oncology and regenerative medicine.

Founders & leadership

Cellbioengines was founded in 2022 by Ajay Vishwakarma and Alexey Bersenev.

AVAjay Vishwakarma
Ajay VishwakarmaFounder and CEOAjay Vishwakarma holds a DMD and MS from Harvard Medical School and MIT, and an MBA; he trained at the Broad Institute and founded Cell BioEngines, a clinical-stage biotech company developing allogeneic stem cell therapies for oncology and regenerative medicine.
AB
Alexey BersenevCo-Founder, CTO

Investors · 2

Related companies · 3

Companies working in the same space as Cellbioengines.

Frequently asked questions

What does Cellbioengines do?
Cell BioEngines is a clinical-stage biotech company developing allogeneic "off-the-shelf" cell therapies from "super donor" stem cells, using transgene-free scalable manufacturing and HLA-guided design. It pursues stem cell-derived therapeutics across oncology and regenerative medicine.
Who founded Cellbioengines?
Cellbioengines was founded by Ajay Vishwakarma, Alexey Bersenev in 2022.
Who are Cellbioengines's investors?
Cellbioengines's investors include SOSV, The Innovation Space.